ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 72 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $552,000 | +123.5% | 1,296,568 | +241.2% | 0.03% | +88.2% |
Q4 2016 | $247,000 | -82.6% | 380,000 | -15.6% | 0.02% | -80.9% |
Q3 2016 | $1,418,000 | +1.9% | 450,000 | 0.0% | 0.09% | -13.6% |
Q2 2016 | $1,391,000 | -14.6% | 450,000 | 0.0% | 0.10% | -24.3% |
Q1 2016 | $1,629,000 | -7.6% | 450,000 | +18.4% | 0.14% | +1.5% |
Q4 2015 | $1,763,000 | -27.6% | 380,000 | -5.0% | 0.13% | -32.3% |
Q3 2015 | $2,436,000 | -39.9% | 400,000 | -14.9% | 0.20% | -33.1% |
Q2 2015 | $4,051,000 | +113.2% | 470,000 | +10.6% | 0.30% | +66.3% |
Q1 2015 | $1,900,000 | – | 425,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 1,900,000 | $16,378,000 | 3.36% |
Hilltop Park Associates LLC | 120,000 | $1,034,000 | 2.05% |
Abingworth LLP | 437,994 | $3,767,000 | 1.71% |
Sio Capital Management, LLC | 238,158 | $2,053,000 | 1.01% |
Rhenman & Partners Asset Management AB | 619,600 | $5,341,000 | 0.64% |
Broadfin Capital, LLC | 1,370,457 | $11,813,000 | 0.64% |
Perceptive Advisors | 1,202,156 | $10,363,000 | 0.62% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 931,257 | $8,027,000 | 0.60% |
WEXFORD CAPITAL LP | 177,500 | $1,530,000 | 0.41% |
Rock Springs Capital Management LP | 470,000 | $4,051,000 | 0.30% |